| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |